Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications

Prostate cancer (PCa) remains the second-leading cause of cancer-related deaths in American men with an estimated mortality of more than 26,000 in 2016 alone. Aggressive and metastatic tumors are treated with androgen deprivation therapies (ADT); however, the tumors acquire resistance and develop in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Yadav, Shalini S., Li, Jinyi, Stockert, Jennifer A., Herzog, Bryan, O'Connor, James, Garzon-Manco, Luis, Parsons, Ramon, Tewari, Ashutosh K., Yadav, Kamlesh K
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2017
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369368/
https://ncbi.nlm.nih.gov/pubmed/28342996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.01.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars